Back to Search
ALBERT KNUTH, M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1508966086Individual
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
036092807(IL)
Research & Publications (20)
[Public knowledge on the role of physical activity in the prevention and treatment of diabetes and hypertension: a population-based study in southern Brazil].
PMID 19300840·Cad Saude Publica·2009
8-other
Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.
PMID 19267427·Cancer Immun·2009
7-preclinical
Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.
PMID 19059635·Gynecol Oncol·2009
3-trial
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg.
PMID 19384924·Int J Cancer·2009
7-preclinical
Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
PMID 18942708·Int J Cancer·2009
8-other
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients.
PMID 18663444·Cancer Immunol Immunother·2009
8-other
[Knowledge on risk factors for chronic diseases: a population-based study].
PMID 19578572·Cad Saude Publica·2009
8-other
Rational development of high-affinity T-cell receptor-like antibodies.
PMID 19307587·Proc Natl Acad Sci U S A·2009
8-other
Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo.
PMID 18616678·Cancer Sci·2008
5-case
Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.
PMID 18041742·Int J Cancer·2008
8-other
Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head.
PMID 18487569·J Clin Oncol·2008
3-trial
New derivatives of vitamin B12 show preferential targeting of tumors.
PMID 18413759·Cancer Res·2008
8-other
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
PMID 18349393·J Clin Oncol·2008
3-trial
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
PMID 18307538·Cancer Sci·2008
8-other
Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients.
PMID 18026951·Cancer Immunol Immunother·2008
8-other
MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.
PMID 18323799·Leukemia·2008
8-other
Is an aggressive surgical approach worthwhile in biliary cancer?
PMID 17956626·Int Semin Surg Oncol·2007
8-other
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
PMID 17944437·Cancer Immun·2007
3-trial
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination.
PMID 17640060·Int J Cancer·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1550 N NORTHWEST HWY, SUITE 220
PARK RIDGE, IL 60068 - Phone
- (847) 824-3198
Quick Facts
- NPI
- 1508966086
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile